Sanaz AttaripourIsfahani

picture of Sanaz  AttaripourIsfahani

Assistant Clinical Professor, Neurology
School of Medicine


M.D.

Phone: (714) 456-6808
Email: sattarip@uci.edu

University of California, Irvine

Irvine, CA 92697
Research Interests
Parkinson's disease Advanced Treatments, Human Motor Control, Neurophysiology of Movement Disorders, Deep Brain Stimulation, Neuroscience of Free Will
Awards and Honors
June 2021: Faculty Teaching Award, Department of Neurology, University of California, Irvine
June 2020: Faculty Teaching Award, Department of Neurology, University of California, Irvine
November 2018: NIH Clinical Center CEO Award in the Science Category, National Institutes of Health, Bethesda, Maryland
June 2015: Humanitarian Resident of the Year, Drexel Neurosciences Institute, Hahnemann University Hospital, Philadelphia, Pennsylvania
Publications
1. Savli, M., Mitterhauser, M., Ding, Y. S., Hahn, A., Neumeister, A., Bauer, A., ..., Sanaz A. Isfahani, …, & Lanzenberger, R. (2012, August). Interaction of inhibitory and excitatory receptors of the serotonergic system: a multi-tracer PET study. In journal of cerebral blood flow and metabolism (vol. 32, pp. s74-s75). 75 Varick St, 9th flr, New York, NY 10013-1917 USA: Nature publishing group.
2. M. Savli, M. Mitterhauser, Y.S. Ding, A. Hahn, A. Neumeister, A. Bauer, W. Wadsak, S. Attaripour Isfahani, A. Höflich, R. Lanzenberger, P.1.e.009 Whole brain relationship of serotonergic receptors, European Neuropsychopharmacology, Volume 22, Supplement 2, 2012, Pages S196-S197, ISSN 0924-977X
3. Savli, M., Bauer, A., Mitterhauser, M., Ding, Y. S., Hahn, A., Kroll, T., . . ., Isfahani, S. A., . . ., Lanzenberger, R. (2012). Normative database of the serotonergic system in healthy subjects using multi-tracer PET. Neuroimage, 63(1), 447-459. doi:10.1016/j.neuroimage.2012.07.001
4. Attaripour Isfahani, S., Dougherty, M., & Gliebus, G. P. (2017). Applicability of long-term electroencephalography in pre-mortem diagnosis of Creutzfeldt–Jakob disease: A case report. SAGE open medical case reports, 5, 2050313X17744482.
5. Vial, F., Attaripour, S., & Hallett, M. (2019). Differentiating tics from functional (psychogenic) movements with electrophysiological tools. Clin Neurophysiol Pract, 4, 143-147. doi:10.1016/j.cnp.2019.04.005
6. Attaripour Isfahani, S., & Hallett, M. (2019). A young woman with dystonia of a foot. Swiss Archives of Neurology, Psychiatry and Psychotherapy, 170(02). https://sanp.ch/article/doi/sanp.2019.03020
7. Kletenik, I., Sillau, S. H., Isfahani, S. A., LaFaver, K., Hallett, M., & Berman, B. D. (2020). Gender as a Risk Factor for Functional Movement Disorders: The Role of Sexual Abuse. Mov Disord Clin Pract, 7(2), 177-181. doi:10.1002/mdc3.12863
8. McGurrin, P., Attaripour, S., Vial, F., & Hallett, M. (2020). Purposely Induced Tics: Electrophysiology. Tremor Other Hyperkinet Mov (N Y), 10. doi:10.7916/tohm.v0.744
9. Vial, F., Akano, E., Attaripour, S., McGurrin, P., & Hallett, M. (2020). Electrophysiological Evidence for Functional (Psychogenic) Essential Palatal Tremor. Tremor Other Hyperkinet Mov (N Y), 10, 10. doi:10.5334/tohm.70
10. Vial, F., Attaripour, S., McGurrin, P., & Hallett, M. (2020). BacAv, a new free online platform for clinical back-averaging. Clin Neurophysiol Pract, 5, 38-42. doi:10.1016/j.cnp.2019.12.001
11. Cif, L., …, Attaripour Isfahani, Sanaz, … , Kurian, Manju A (2020). "KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation." Brain.
12. Attaripour Isfahani S., Alter K. (2020) Botulinum Toxin for Pediatric Patients, Who? For What? When?. In: Jabbari B. (eds) Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-50691-9_11
 
13. Parker JA, Merchant SH, Attaripour-Isfahani S, Cho HJ, McGurrin P, Brooks BP, La Spada AR, Hallett M, Huryn LA, Horovitz SG. In vivo assessment of neurodegeneration in Spinocerebellar Ataxia type 7. Neuroimage Clin. 2021;29:102561. doi: 10.1016/j.nicl.2021.102561. Epub 2021 Jan 19. PMID: 33516934; PMCID: PMC7848632.
 
14. N Shah, R Castro, SNA Isfahani, RM Vyas (2021), Cost Effectiveness of Erenumab and Surgical Trigger Site Deactivation in the Treatment of Migraine Headaches: A Systematic Review, Journal of Craniofacial Surgery 32 (4), e398-e401
Professional Societies
American Academy of Neurology
International Parkinson and Movement Disorder Society
Functional Neurological Disorder Society
International Restless Legs Syndrome Study Group
International neurotoxin Association
Last updated
12/02/2021